AmorChem

AmorChem does not conduct clinical trials or have its own clinical results. It finances and incubates early-stage academic research to create new biotech companies and advance programs to preclinical proof-of-concept. "AmorChem is a leading early stage venture fund dedicated to creating the next generation of biotech companies from academic research... focuses its investments on the translational research necessary to bridge this innovation gap". "A leading VC fund focused on investing in promising life science projects from research-stage to preclinical proof-of-concept, after which we seed newcos...". No direct pipeline or clinical results for AmorChem as an entity.